Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7508)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 21, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bowden S, Locarnini S, Chang TT, Chao YC, Han KH, Gish RG, de Man RA, Yu M, Llamoso C, Tang H. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. World J Gastroenterol 2015; 21(15): 4644-4651 [PMID: 25914474 DOI: 10.3748/wjg.v21.i15.4644] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i15/4644.htm |
| Number | Citing Articles |
| 1 |
Ju-Tao Guo, Haitao Guo. Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. Antiviral Research 2015; 122: 91 doi: 10.1016/j.antiviral.2015.08.005
|
| 2 |
Lena Allweiss, Maura Dandri. The Role of cccDNA in HBV Maintenance. Viruses 2017; 9(6): 156 doi: 10.3390/v9060156
|
| 3 |
Takehisa Watanabe, Sanae Hayashi, Yasuhito Tanaka. Drug Discovery Study Aimed at a Functional Cure for HBV. Viruses 2022; 14(7): 1393 doi: 10.3390/v14071393
|
| 4 |
Yan-Wei Zhong, Yan-Min Shi, Fang Chu, Jie Liu, Ce Shi, Jiao-Jiao Xu, Peng Liu, Yan-Jie Bai, Xiao-He Xiao, Xiu-Chang Zhang, Min Zhang. Prediction for HBsAg seroconversion in children with chronic hepatitis B. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06883-1
|
| 5 |
Ching-Lung Lai, Danny Wong, Philip Ip, Malgorzata Kopaniszen, Wai-Kay Seto, James Fung, Fung-Yu Huang, Brian Lee, Giuseppe Cullaro, Chun Kong Chong, Ringo Wu, Charles Cheng, John Yuen, Vincent Ngai, Man-Fung Yuen. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B. Journal of Hepatology 2017; 66(2): 275 doi: 10.1016/j.jhep.2016.08.022
|
| 6 |
Kazuhisa Murai, Takayoshi Shirasaki, Masao Honda, Ryogo Shimizu, Tetsuro Shimakami, Saki Nakasho, Natsumi Shirasaki, Hikari Okada, Yoshio Sakai, Taro Yamashita, Shuichi Kaneko. Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro. International Journal of Molecular Sciences 2018; 19(2): 108 doi: 10.3390/ijms19020108
|
| 7 |
Jie-Li Hu, Ai-Long Huang. Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review. Microorganisms 2023; 11(3): 600 doi: 10.3390/microorganisms11030600
|
| 8 |
Maura Dandri, Joerg Petersen. <p>cccDNA Maintenance in Chronic Hepatitis B – Targeting the Matrix of Viral Replication</p>. Infection and Drug Resistance 2020; : 3873 doi: 10.2147/IDR.S240472
|
| 9 |
Soo Ryang Kim, Soo Ki Kim. Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma. Diagnostics 2023; 13(20): 3212 doi: 10.3390/diagnostics13203212
|
| 10 |
Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, Ruihong Wu, Qinglong Jin, Hongqin Xu, Xiuzhu Gao, Lei Yu, Yuping Chen, Jia Shang, Longgen Liu, Shuqin Zhang, Yongfang Jiang, Mingxiang Zhang, Qiaoxia Tong, Lunli Zhang, Youwen Tan, Anlin Ma, Shuangsuo Dang, Bin Xu, Zhenjing Jin, Jia Li, Xiaobo Li, Fengmin Lu, Junqi Niu. Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks. International Journal of Infectious Diseases 2020; 99: 171 doi: 10.1016/j.ijid.2020.07.031
|
| 11 |
Jennifer J. Chang, Neaka Mohtashemi, Debika Bhattacharya. Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era. Current HIV/AIDS Reports 2018; 15(2): 172 doi: 10.1007/s11904-018-0379-y
|
| 12 |
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Hiroko Shindo, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto. Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma. Hepatology Research 2019; 49(1): 51 doi: 10.1111/hepr.13277
|
| 13 |
Naveen Kumar, Shalini Sharma, Ram Kumar, Bhupendra N. Tripathi, Sanjay Barua, Hinh Ly, Barry T. Rouse. Host-Directed Antiviral Therapy. Clinical Microbiology Reviews 2020; 33(3) doi: 10.1128/CMR.00168-19
|
| 14 |
Xiaomei Wang, Xiumei Chi, Ruihong Wu, Hongqin Xu, Xiuzhu Gao, Lei Yu, Longgen Liu, Mingxiang Zhang, Youwen Tan, Junqi Niu, Qinglong Jin. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment. Virology Journal 2021; 18(1) doi: 10.1186/s12985-020-01471-2
|
| 15 |
Zijing Wang, Kazunori Kawaguchi, Masao Honda, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Shuichi Kaneko. Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection. Biochemical and Biophysical Research Communications 2018; 501(3): 682 doi: 10.1016/j.bbrc.2018.04.236
|
| 16 |
Marçal Yll, Maria Francesca Cortese, Mercedes Guerrero-Murillo, Gerard Orriols, Josep Gregori, Rosario Casillas, Carolina González, Sara Sopena, Cristina Godoy, Marta Vila, David Tabernero, Josep Quer, Ariadna Rando, Rosa Lopez-Martinez, Rafael Esteban, Mar Riveiro-Barciela, Maria Buti, Francisco Rodríguez-Frías. Conservation and variability of hepatitis B core at different chronic hepatitis stages. World Journal of Gastroenterology 2020; 26(20): 2584-2598 doi: 10.3748/wjg.v26.i20.2584
|
| 17 |
Florian MORETTO, François-Xavier CATHERINE, Clémentine ESTEVE, Mathieu BLOT, Lionel PIROTH. Isolated Anti-HBc: Significance and Management. Journal of Clinical Medicine 2020; 9(1): 202 doi: 10.3390/jcm9010202
|
| 18 |
François Villeret, Fanny Lebossé, Sylvie Radenne, Didier Samuel, Bruno Roche, Jean-Yves Mabrut, Vincent Leroy, Georges-Philippe Pageaux, Rodolphe Anty, Sylvie Thevenon, Sinafa Si Ahmed, Aaron Hamilton, Marintha Heil, Caroline Scholtès, Massimo Levrero, Barbara Testoni, Fabien Zoulim, Françoise Berby, Isabelle Bordes, Daniel Cherqui, Tarek Debs, Christian Ducerf, Jean-Charles Duclos-Valle, Marie-Noëlle Hilleret, Antonio Iannelli, Kayvan Mohkam, Francis Navarro. Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis. JHEP Reports 2023; 5(6): 100728 doi: 10.1016/j.jhepr.2023.100728
|
| 19 |
Enagnon K. Alidjinou, Charlotte Michel, Valérie Canva, Faïza Ajana, Didier Hober, Laurence Bocket. Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues. Journal of Medical Virology 2018; 90(5): 989 doi: 10.1002/jmv.25028
|
| 20 |
Yingshan Chen, Yongxuan Yao, Kaitao Zhao, Canyu Liu, Yifei Yuan, Hao Sun, Dan Huang, Yi Zheng, Yuan Zhou, Jizheng Chen, Yun Wang, Chunchen Wu, Bixiang Zhang, Yujuan Guan, Feng Li, Rongjuan Pei, Xinwen Chen, J.-H. James Ou. DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation. Journal of Virology 2022; 96(13) doi: 10.1128/jvi.00585-22
|
| 21 |
Salvatore Chirumbolo. Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway. Inflammation Research 2018; 67(3): 203 doi: 10.1007/s00011-017-1111-x
|
| 22 |
Maura Dandri, Joerg Petersen. Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential. Clinical Infectious Diseases 2016; 62(suppl 4): S281 doi: 10.1093/cid/ciw023
|
| 23 |
Jie-Li Hu, Ai-Long Huang. Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics. Virologica Sinica 2024; 39(1): 9 doi: 10.1016/j.virs.2023.12.005
|